Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMME8LH)

Drug Name
Alitretinoin Drug Info
Indication
Disease Entry ICD 11 Status REF
Kaposi sarcoma 2B57 Approved [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
449171
ChEBI ID
CHEMBL705
CAS Number
CAS 5300-03-8
TTD Drug ID
DMME8LH
VARIDT Drug ID
DR00315
INTEDE Drug ID
DR2501

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DME
DOT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Retinoic acid receptor RXR-alpha (RXRA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [13]
2-chloro-5-nitro-N-phenylbenzamide DMUGQIV Discovery agent N.A. Investigative [14]
AGN-34 DM5ECDM Discovery agent N.A. Investigative [15]
LG100754 DMEK4FY Discovery agent N.A. Investigative [16]
(5BETA)-PREGNANE-3,20-DIONE DMVQ6RN Discovery agent N.A. Investigative [14]
phytanic acid DMSZ1RB Discovery agent N.A. Investigative [17]
CD3254 DM38MU1 Discovery agent N.A. Investigative [18]
UVI3003 DM95UI1 Discovery agent N.A. Investigative [19]
Tributylstannanyl DMHN7CB Discovery agent N.A. Investigative [14]
methoprene acid DM58A0W Discovery agent N.A. Investigative [20]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Retinoic acid receptor RXR-gamma (RXRG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [21]
NRX-4204 DMYXOU2 Diabetic complication 5A2Y Phase 2 [22]
IRX4204 DM9SCME Breast cancer 2C60-2C65 Phase 1 [23]
9cUAB-30 DMYKPXJ Solid tumour/cancer 2A00-2F9Z Phase 1 [24]
SR-11237 DMQG3CK Solid tumour/cancer 2A00-2F9Z Terminated [25]
AGN-34 DM5ECDM Discovery agent N.A. Investigative [15]
LG100754 DMEK4FY Discovery agent N.A. Investigative [26]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Targeting Retinoic acid receptor RXR-beta (RXRB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AGN-34 DM5ECDM Discovery agent N.A. Investigative [15]
LG100754 DMEK4FY Discovery agent N.A. Investigative [26]
Drug(s) Targeting Retinoic acid receptor beta (RARB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [27]
PMID27336223-Compound-10 DMYUP6G N. A. N. A. Patented [28]
PMID27336223-Compound-8 DM460D1 N. A. N. A. Patented [28]
PMID27336223-Compound-7 DM9QM6I N. A. N. A. Patented [28]
CD666 DMC8X9Y Discovery agent N.A. Investigative [29]
AGN193109 DMC0YOE Discovery agent N.A. Investigative [30]
AC55649 DM4JNY9 Discovery agent N.A. Investigative [31]
BMS641 DMRT7G3 Discovery agent N.A. Investigative [32]
AC261066 DMSKE1I Discovery agent N.A. Investigative [31]
TTNPB DMSABD0 Discovery agent N.A. Investigative [33]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Retinoic acid receptor gamma (RARG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [34]
Trifarotene DMOL793 Acne vulgaris ED80 Approved [35]
Tazarotene DM8SMD1 Acne vulgaris ED80 Approved [36]
Palovarotene DMAD2OZ Fibrodysplasia ossificans progressiva FB31.1 Approved [37]
PMID27336223-Compound-13 DMSZLYD N. A. N. A. Patented [28]
PMID27336223-Compound-12 DMT4P7K N. A. N. A. Patented [28]
PMID27336223-Compound-14 DMC41MA N. A. N. A. Patented [28]
PMID27336223-Compound-11 DMBN6KU N. A. N. A. Patented [28]
PMID27336223-Compound-15 DMIYCFE N. A. N. A. Patented [28]
PMID27336223-Compound-9 DM6V13W N. A. N. A. Patented [28]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 3A4 (CYP3A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [38]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [39]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [40]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [41]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [42]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [43]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [44]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [45]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [39]
Verapamil DMA7PEW Angina pectoris BA40 Approved [46]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Involucrin (IVL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcipotriol DM03CP7 Psoriasis EA90 Approved [47]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [48]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [49]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [50]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [47]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [51]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [52]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [53]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [9]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Choriogonadotropin subunit beta 3 (CGB3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [54]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [55]
Testosterone enanthate DMB6871 N. A. N. A. Approved [56]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [58]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [59]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Bezafibrate DMZDCS0 Hypercholesterolaemia 5C80.0 Approved [61]
Testosterone DM7HUNW Hot flushes GA30 Approved [62]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [63]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein-glutamine gamma-glutamyltransferase 2 (TGM2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Etretinate DM2CZFA Keratosis ED56 Approved [64]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [65]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [67]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Ethanol DMDRQZU Chronic pain MG30 Approved [69]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [70]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein-arginine deiminase type-4 (PADI4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [72]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [73]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [74]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [75]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [76]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [77]
paraquat DMR8O3X Discovery agent N.A. Investigative [78]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By AH receptor-interacting protein (AIP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [79]
Methotrexate DM2TEOL Anterior urethra cancer Approved [80]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [81]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [72]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Pirin (PIR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [84]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [86]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [87]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [89]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [89]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [81]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [90]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Suppressor of cytokine signaling 2 (SOCS2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [91]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [93]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [95]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [96]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transforming growth factor beta-1-induced transcript 1 protein (TGFB1I1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Testosterone DM7HUNW Hot flushes GA30 Approved [98]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [100]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By RNA/RNP complex-1-interacting phosphatase (DUSP11)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [101]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [102]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [83]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [103]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [104]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [105]
Glyphosate DM0AFY7 Malaria 1F40-1F45 Investigative [106]
Milchsaure DM462BT Pruritus EC90 Investigative [107]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type II cytoskeletal 75 (KRT75)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [108]
Arsenic DMTL2Y1 N. A. N. A. Approved [109]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [110]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [74]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [75]
all-trans-4-oxo-retinoic acid DMM2R1N Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Alpha-1-antichymotrypsin (SERPINA3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [112]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [113]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [114]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [112]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [112]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [115]
Fluoxetine DM3PD2C Bipolar depression Approved [112]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type I cytoskeletal 14 (KRT14)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [116]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [49]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [117]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Folic Acid DMEMBJC Colorectal carcinoma Approved [118]
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [119]
Methamphetamine DMPM4SK Anxiety Approved [120]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [121]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type II cytoskeletal 6A (KRT6A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [116]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [122]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [124]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [59]
Arsenic DMTL2Y1 N. A. N. A. Approved [125]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [126]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [127]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type II cytoskeletal 1 (KRT1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [128]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [116]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [129]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [130]
Arsenic DMTL2Y1 N. A. N. A. Approved [131]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [132]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [133]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-A8 (S100A8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [134]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [135]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [134]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [136]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [137]
Halothane DM80OZ5 Anaesthesia 9A78.6 Approved [134]
Dicloxacillin DM8EU0Z Bacterial infection 1A00-1C4Z Approved [134]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [93]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Plasminogen activator inhibitor 2 (SERPINB2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [138]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [139]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [140]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [141]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [142]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fibroblast growth factor 1 (FGF1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [138]
Methotrexate DM2TEOL Anterior urethra cancer Approved [144]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [145]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [95]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [146]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Arsenic DMTL2Y1 N. A. N. A. Approved [109]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-A9 (S100A9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [134]
Methotrexate DM2TEOL Anterior urethra cancer Approved [80]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [135]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [87]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [50]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [137]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [147]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neurofilament light polypeptide (NEFL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [148]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [149]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [150]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type II cytoskeletal 7 (KRT7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [151]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Selenium DM25CGV N. A. N. A. Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [95]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [52]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Stromelysin-2 (MMP10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [99]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [138]
Methotrexate DM2TEOL Anterior urethra cancer Approved [144]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [135]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [144]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Haloperidol DM96SE0 Delirium Approved [152]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Growth-regulated alpha protein (CXCL1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [138]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [153]
Selenium DM25CGV N. A. N. A. Approved [154]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [115]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [156]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [144]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Collagen alpha-1(VI) chain (COL6A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Testosterone enanthate DMB6871 N. A. N. A. Approved [158]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [159]
Paclitaxel DMLB81S Breast carcinoma Approved [160]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [161]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type I cytoskeletal 10 (KRT10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcipotriol DM03CP7 Psoriasis EA90 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [129]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [101]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type II cytoskeletal 5 (KRT5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [116]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [117]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [119]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [163]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type I cytoskeletal 15 (KRT15)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [84]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [135]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [89]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [81]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [89]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Filaggrin (FLG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcipotriol DM03CP7 Psoriasis EA90 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [50]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [47]
Folic Acid DMEMBJC Colorectal carcinoma Approved [164]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [53]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [50]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [133]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cornifin-B (SPRR1B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [138]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [48]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [126]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [165]
phorbol 12-myristate 13-acetate DMJWD62 Acute myeloid leukaemia 2A60 Phase 2 [166]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [75]
all-trans-4-oxo-retinoic acid DMM2R1N Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-A1 (S100A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [81]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [50]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [127]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Laminin subunit alpha-2 (LAMA2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [168]
Arsenic DMTL2Y1 N. A. N. A. Approved [169]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [83]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [170]
Methotrexate DM2TEOL Anterior urethra cancer Approved [171]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Collagen alpha-2(VIII) chain (COL8A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [136]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [172]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [173]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [174]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [170]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [92]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [75]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-A7 (S100A7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [50]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [165]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [75]
Milchsaure DM462BT Pruritus EC90 Investigative [107]
all-trans-4-oxo-retinoic acid DMM2R1N Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Cyclin-dependent kinase inhibitor 1C (CDKN1C)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [84]
Selenium DM25CGV N. A. N. A. Approved [79]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [135]
Quercetin DM3NC4M Obesity 5B81 Approved [176]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [95]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [177]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Serpin B8 (SERPINB8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [81]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [52]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Serpin B9 (SERPINB9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Quercetin DM3NC4M Obesity 5B81 Approved [178]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [179]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [93]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Epithelial membrane protein 1 (EMP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [84]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [180]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [180]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Microfibrillar-associated protein 2 (MFAP2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [150]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [182]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [183]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Rho-related GTP-binding protein RhoB (RHOB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [156]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [184]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [142]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [185]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [186]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sterol 26-hydroxylase, mitochondrial (CYP27A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clavulanate DM2FGRT Bacteremia 1A73 Approved [187]
Methotrexate DM2TEOL Anterior urethra cancer Approved [188]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [91]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [189]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [190]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [191]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Desmocollin-1 (DSC1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [115]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [115]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [130]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [132]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [192]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [193]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Chromobox protein homolog 3 (CBX3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [81]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [52]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Bortezomib DMNO38U Leukemia Approved [177]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Eukaryotic translation initiation factor 4E-binding protein 2 (EIF4EBP2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [194]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [195]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [196]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-10 receptor subunit alpha (IL10RA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [52]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [172]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
Teriflunomide DMQ2FKJ Hyperlipidaemia 5C80 Approved [197]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [198]
Arsenic DMTL2Y1 N. A. N. A. Approved [109]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [199]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fas-activated serine/threonine kinase (FASTK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
Testosterone enanthate DMB6871 N. A. N. A. Approved [158]
Folic Acid DMEMBJC Colorectal carcinoma Approved [164]
Menthol DMG2KW7 Back pain ME84.Z Approved [200]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Bortezomib DMNO38U Leukemia Approved [177]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [201]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Growth factor receptor-bound protein 7 (GRB7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [93]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [130]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [202]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [99]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [203]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Laminin subunit alpha-3 (LAMA3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [204]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [89]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [89]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [89]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [89]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein FAM3C (FAM3C)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [86]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [205]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [198]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [202]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [206]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [207]
Paclitaxel DMLB81S Breast carcinoma Approved [207]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By E3 ubiquitin-protein ligase RNF5 (RNF5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [202]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [208]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [83]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [79]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [209]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [75]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [210]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Collagen alpha-1(XVII) chain (COL17A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [173]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Arsenic DMTL2Y1 N. A. N. A. Approved [109]
Ximelegatran DMU8ANS Myocardial infarction BA41-BA43 Approved [211]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [212]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [213]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Laminin subunit gamma-3 (LAMC3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [5]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [5]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [132]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [92]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [75]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [214]
all-trans-4-oxo-retinoic acid DMM2R1N Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Bcl-2-like protein 11 (BCL2L11)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [215]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [216]
Quercetin DM3NC4M Obesity 5B81 Approved [217]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Remdesivir DMBFZ6L Coronavirus Disease 2019 (COVID-19) 1D6Y Approved [218]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [219]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [220]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [221]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cyclin-dependent kinase inhibitor 1 (CDKN1A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [222]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [151]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [223]
Gefitinib DM15F0X Colon adenocarcinoma Approved [224]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [225]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [226]
Etretinate DM2CZFA Keratosis ED56 Approved [227]
Prednisone DM2HG4X Acute asthma CA23 Approved [228]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [229]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [230]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cyclin-dependent kinase inhibitor 1B (CDKN1B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [231]
Gefitinib DM15F0X Colon adenocarcinoma Approved [232]
Prednisone DM2HG4X Acute asthma CA23 Approved [228]
Methotrexate DM2TEOL Anterior urethra cancer Approved [233]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [234]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [235]
Quercetin DM3NC4M Obesity 5B81 Approved [236]
Fluoxetine DM3PD2C Bipolar depression Approved [237]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [238]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [239]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By 17-beta-hydroxysteroid dehydrogenase type 1 (HSD17B1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [240]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [241]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Metyrapone DMI7FVQ Cushing disease 5A70 Approved [242]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [243]
Dutasteride DMQ4TJK Benign prostatic hyperplasia GA90 Approved [244]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [245]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [243]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [246]
Estrone DM5T6US Acne vulgaris ED80 Approved [240]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein Meis1 (MEIS1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [9]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Arsenic DMTL2Y1 N. A. N. A. Approved [109]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [247]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [72]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein Meis2 (MEIS2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
Ethanol DMDRQZU Chronic pain MG30 Approved [249]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [9]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Collagen alpha-1(I) chain (COL1A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [250]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [251]
Diazepam DM08E9O Alcohol withdrawal Approved [252]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [253]
Methotrexate DM2TEOL Anterior urethra cancer Approved [254]
Ceruletide DM2WE5K Caerulein stimulated gastric and pancreatic secretion 5A4Y Approved [255]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [256]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [257]
Quercetin DM3NC4M Obesity 5B81 Approved [258]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type I cytoskeletal 18 (KRT18)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [259]
Selenium DM25CGV N. A. N. A. Approved [79]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [260]
Methotrexate DM2TEOL Anterior urethra cancer Approved [261]
Quercetin DM3NC4M Obesity 5B81 Approved [262]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [263]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Keratin, type II cytoskeletal 8 (KRT8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Selenium DM25CGV N. A. N. A. Approved [79]
Methotrexate DM2TEOL Anterior urethra cancer Approved [261]
Quercetin DM3NC4M Obesity 5B81 Approved [264]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [156]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [49]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [129]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Collagen alpha-2(IV) chain (COL4A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [265]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [86]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [265]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Testosterone enanthate DMB6871 N. A. N. A. Approved [158]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [9]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [266]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-1 (CDH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [267]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [268]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [269]
Liraglutide DM3FXPS Non-insulin dependent diabetes 5A11 Approved [270]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [271]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [241]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [272]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor receptor superfamily member 6 (FAS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [226]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [273]
Methotrexate DM2TEOL Anterior urethra cancer Approved [274]
Epinephrine DM3KJBC Acute asthma CA23 Approved [275]
Quercetin DM3NC4M Obesity 5B81 Approved [276]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [277]
Fructose DM43AN2 Vomiting MD90 Approved [278]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Retinoic acid receptor responder protein 1 (RARRES1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Methotrexate DM2TEOL Anterior urethra cancer Approved [144]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [280]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [281]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [9]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [150]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [144]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [282]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein MOX-1 (MEOX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [283]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [283]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [283]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [284]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [283]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [283]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [283]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Hepatocyte nuclear factor 3-alpha (FOXA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [285]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [84]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [116]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [286]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Oxidized low-density lipoprotein receptor 1 (OLR1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [136]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [93]
Aldosterone DM9S2JW Hypertension BA00-BA04 Approved [287]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [70]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [100]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [9]
Nifedipine DMSVOZT Angina pectoris BA40 Approved [288]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [289]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Mucin-5AC (MUC5AC)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [290]
Selenium DM25CGV N. A. N. A. Approved [291]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [292]
Capsaicin DMGMF6V Back pain ME84.Z Approved [293]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [9]
Dihydroxyacetone DMM1LG2 Sunburn EJ40 Approved [294]
Bleomycin DMNER5S Cervical cancer 2C77.0 Approved [295]
Arsenic DMTL2Y1 N. A. N. A. Approved [296]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor GATA-6 (GATA6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [85]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [297]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [9]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Indomethacin DMSC4A7 Bursitis Approved [298]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [84]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Phospholipase A and acyltransferase 4 (PLAAT4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [54]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [137]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [52]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [9]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By MHC class II transactivator (CIITA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [299]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [300]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [204]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [301]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [149]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [302]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [183]
Arsenic DMTL2Y1 N. A. N. A. Approved [303]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [301]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By RNA binding protein fox-1 homolog 3 (RBFOX3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [304]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Arsenic DMTL2Y1 N. A. N. A. Approved [109]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [305]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [92]
PDX-101 DM6OC53 Plasma cell myeloma 2A83.1 Phase 2 [92]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [75]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor receptor superfamily member 10A (TNFRSF10A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [306]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [156]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [307]
Vismodegib DM5IXKQ Basal cell carcinoma 2C32 Approved [308]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [309]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [310]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [311]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [312]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nuclear receptor subfamily 5 group A member 2 (NR5A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [285]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [91]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [313]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [52]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Arsenic DMTL2Y1 N. A. N. A. Approved [109]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [315]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor SOX-1 (SOX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [313]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [284]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [316]
Arsenic DMTL2Y1 N. A. N. A. Approved [317]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [318]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [92]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [92]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [319]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Stearoyl-CoA desaturase (SCD)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clavulanate DM2FGRT Bacteremia 1A73 Approved [187]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [320]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [320]
Methotrexate DM2TEOL Anterior urethra cancer Approved [80]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [115]
Fluoxetine DM3PD2C Bipolar depression Approved [320]
Fructose DM43AN2 Vomiting MD90 Approved [321]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [54]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [320]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [230]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [322]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [323]
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [324]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [325]
Selenium DM25CGV N. A. N. A. Approved [326]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [230]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [327]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [327]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fatty acid-binding protein, brain (FABP7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [313]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [86]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [284]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Chenodiol DMQ8JIK Cholelithiasis DC11 Approved [328]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [329]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [92]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [330]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [101]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Kallikrein-10 (KLK10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [331]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [101]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [149]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [130]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [332]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [170]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [207]
Captopril DM458UM Chronic heart failure BD1Z Approved [250]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [92]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neuronal migration protein doublecortin (DCX)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [204]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [316]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [333]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [75]
Glyphosate DM0AFY7 Malaria 1F40-1F45 Investigative [334]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [314]
Deguelin DMXT7WG Esophageal squamous cell carcinoma 2E60.1 Investigative [335]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Microphthalmia-associated transcription factor (MITF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [336]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [337]
Quercetin DM3NC4M Obesity 5B81 Approved [178]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [313]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [338]
Vemurafenib DM62UG5 Melanoma 2C30 Approved [339]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [93]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By ATP-binding cassette sub-family C member 6 (ABCC6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzbromarone DMC3YUA Gout FA25 Approved [340]
Verapamil DMA7PEW Angina pectoris BA40 Approved [340]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [341]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [7]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [342]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [343]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [344]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transforming growth factor beta-1 proprotein (TGFB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [345]
Gabapentin DM6T924 Complex partial seizure 8A68.0 Approved [250]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [346]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [347]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [348]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [349]
Prednisone DM2HG4X Acute asthma CA23 Approved [350]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [351]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [352]
Methotrexate DM2TEOL Anterior urethra cancer Approved [80]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Osteocalcin (BGLAP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [353]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [354]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [253]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [355]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [356]
Pamidronate DMB4AVP Bone Paget disease Approved [357]
Falecalcitrol DMBI9ZJ Hyperparathyroidism 5A51 Approved [358]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [359]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [297]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Annexin A1 (ANXA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [360]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [115]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [361]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [362]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [137]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [363]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-B (S100B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [204]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Norepinephrine DMOUC09 Alopecia ED70 Approved [364]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [247]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [206]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [206]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [365]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Retinoblastoma-associated protein (RB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [366]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [231]
Gefitinib DM15F0X Colon adenocarcinoma Approved [367]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [225]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [368]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [216]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [369]
Methotrexate DM2TEOL Anterior urethra cancer Approved [370]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [371]
Quercetin DM3NC4M Obesity 5B81 Approved [176]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Synaptophysin (SYP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [368]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [10]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [95]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ethanol DMDRQZU Chronic pain MG30 Approved [372]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [373]
Methamphetamine DMPM4SK Anxiety Approved [374]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [202]
Urethane DM7NSI0 N. A. N. A. Phase 4 [375]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Hepatocyte growth factor receptor (MET)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cabozantinib DMIYDT4 Medullary thyroid gland carcinoma Approved [376]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [219]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [377]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [377]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [377]
Methotrexate DM2TEOL Anterior urethra cancer Approved [144]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [377]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [378]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [144]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Poly polymerase 1 (PARP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [138]
Gefitinib DM15F0X Colon adenocarcinoma Approved [379]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [380]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [273]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [381]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [229]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [381]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [382]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [383]
Methotrexate DM2TEOL Anterior urethra cancer Approved [384]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Microtubule-associated protein 2 (MAP2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [385]
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [313]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [386]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [316]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neurofilament heavy polypeptide (NEFH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [151]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [313]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Scopolamine DMOM8AL Addictive disorder 6C50-6C5Z Approved [387]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [182]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [198]
Arsenic DMTL2Y1 N. A. N. A. Approved [388]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [110]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Parathyroid hormone-related protein (PTHLH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [155]
Ceruletide DM2WE5K Caerulein stimulated gastric and pancreatic secretion 5A4Y Approved [255]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [389]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Testosterone DM7HUNW Hot flushes GA30 Approved [390]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [93]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [95]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Glial fibrillary acidic protein (GFAP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Penicillin V DMKVOYF Acute otitis media AB00 Approved [250]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [250]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [391]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [392]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [393]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
Haloperidol DM96SE0 Delirium Approved [152]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Ethanol DMDRQZU Chronic pain MG30 Approved [394]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interferon gamma receptor 1 (IFNGR1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [323]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [84]
Methotrexate DM2TEOL Anterior urethra cancer Approved [306]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Clozapine DMFC71L Schizophrenia 6A20 Approved [395]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [396]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Glutathione peroxidase 2 (GPX2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [397]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [226]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [187]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [91]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [341]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [398]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [399]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [400]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-2 (CDH2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [368]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [115]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [10]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [401]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [402]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [403]
Testosterone DM7HUNW Hot flushes GA30 Approved [404]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [148]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nucleoside diphosphate kinase B (NME2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [6]
Testosterone DM7HUNW Hot flushes GA30 Approved [181]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [405]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Capsaicin DMGMF6V Back pain ME84.Z Approved [406]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [407]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [408]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [409]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [410]
Arsenic DMTL2Y1 N. A. N. A. Approved [411]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [412]
Quercetin DM3NC4M Obesity 5B81 Approved [413]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [6]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [49]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [363]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [129]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [414]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Ethanol DMDRQZU Chronic pain MG30 Approved [394]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Paired box protein Pax-6 (PAX6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [313]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [283]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [283]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [415]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [283]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [283]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [416]
Dabigatran DMDI6R4 Stroke 8B20 Approved [283]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cellular retinoic acid-binding protein 2 (CRABP2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [180]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [417]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [180]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [418]
Panobinostat DM58WKG Chronic graft versus host disease Approved [92]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [95]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [419]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By G1/S-specific cyclin-D3 (CCND3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [420]
Gefitinib DM15F0X Colon adenocarcinoma Approved [232]
Quercetin DM3NC4M Obesity 5B81 Approved [176]
Furazolidone DM3P6V7 Diarrhea ME05.1 Approved [421]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [422]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [423]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [424]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [204]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [425]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [88]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By T-lymphocyte activation antigen CD80 (CD80)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [426]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [427]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [428]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [52]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [429]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [11]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [430]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [431]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [432]
Arsenic DMTL2Y1 N. A. N. A. Approved [433]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Type I iodothyronine deiodinase (DIO1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [434]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [179]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [101]
Ergocalciferol DMHO0AR Hypoparathyroidism 5A50 Approved [435]
Masoprocol DMMVNZ0 Prostate cancer 2C82.0 Approved [435]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [436]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [437]
Oxytetracycline DMOVH1M Actinomycosis Approved [438]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor ligand superfamily member 10 (TNFSF10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [324]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [9]
Selenium DM25CGV N. A. N. A. Approved [79]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [439]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [440]
Methotrexate DM2TEOL Anterior urethra cancer Approved [441]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [442]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [443]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [444]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neural retina-specific leucine zipper protein (NRL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gefitinib DM15F0X Colon adenocarcinoma Approved [445]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [446]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [179]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Urethane DM7NSI0 N. A. N. A. Phase 4 [375]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [319]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [210]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [259]
TTNPB DMSABD0 Discovery agent N.A. Investigative [446]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By CD83 antigen (CD83)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [441]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [447]
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [156]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [137]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [448]
Exemestane DM9HPW3 Hormonally-responsive breast cancer 2C60-2C65 Approved [449]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [81]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein TGIF1 (TGIF1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [54]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [450]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [451]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [143]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [452]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [315]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [110]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Long-chain fatty acid transport protein 1 (SLC27A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [80]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [453]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [177]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [130]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Type II iodothyronine deiodinase (DIO2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [138]
Quercetin DM3NC4M Obesity 5B81 Approved [454]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [455]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [10]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [144]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [168]
Ergocalciferol DMHO0AR Hypoparathyroidism 5A50 Approved [435]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [149]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Dehydrogenase/reductase SDR family member 9 (DHRS9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [156]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [456]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [86]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [95]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [70]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [457]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [247]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [83]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [458]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 4F11 (CYP4F11)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [85]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [91]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [459]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [204]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Ethanol DMDRQZU Chronic pain MG30 Approved [460]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [82]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [436]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [85]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [461]
Fructose DM43AN2 Vomiting MD90 Approved [321]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [462]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [463]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [204]
Ketotifen DM74XKS Allergic conjunctivitis 9A60.02 Approved [464]
Riboflavin DM8YMWE Acne vulgaris ED80 Approved [465]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [465]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ras-related protein Rab-27A (RAB27A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [71]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [86]
Leflunomide DMR8ONJ Arthritis FA20 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [99]
Testosterone enanthate DMB6871 N. A. N. A. Approved [158]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [466]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [68]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [162]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [198]
Arsenic DMTL2Y1 N. A. N. A. Approved [109]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cellular retinoic acid-binding protein 1 (CRABP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [313]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [123]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [467]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [467]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [468]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [165]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [203]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [330]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Retinoic acid receptor beta (RARB) TTISP28 RARB_HUMAN Agonist [2]
Retinoic acid receptor gamma (RARG) TT1Q3IE RARG_HUMAN Modulator [2]
Retinoic acid receptor RXR-alpha (RXRA) TT6PEUO RXRA_HUMAN Agonist [2]
Retinoic acid receptor RXR-beta (RXRB) TTKLV96 RXRB_HUMAN Agonist [2]
Retinoic acid receptor RXR-gamma (RXRG) TTH029C RXRG_HUMAN Agonist [2]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 3A4 (CYP3A4) Main DME DE4LYSA CP3A4_HUMAN Substrate [3]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
17-beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) OT6EBDHM DHB1_HUMAN Gene/Protein Processing [4]
AH receptor-interacting protein (AIP) OTDJ3OSV AIP_HUMAN Gene/Protein Processing [5]
Alpha-1-antichymotrypsin (SERPINA3) OT9BP2S0 AACT_HUMAN Gene/Protein Processing [5]
Annexin A1 (ANXA1) OT5OFDJC ANXA1_HUMAN Gene/Protein Processing [6]
ATP-binding cassette sub-family C member 6 (ABCC6) OTZT0LKT MRP6_HUMAN Gene/Protein Processing [7]
Bcl-2-like protein 11 (BCL2L11) OTNQQWFJ B2L11_HUMAN Gene/Protein Processing [8]
Cadherin-1 (CDH1) OTFJMXPM CADH1_HUMAN Gene/Protein Processing [9]
Cadherin-2 (CDH2) OTH0Y56P CADH2_HUMAN Gene/Protein Processing [10]
CD83 antigen (CD83) OT1V4WQF CD83_HUMAN Gene/Protein Processing [11]
Cellular retinoic acid-binding protein 1 (CRABP1) OTISDG5X RABP1_HUMAN Drug Response [12]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2645).
2 Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):30-4.
3 Alitretinoin in dermatology-an update. Indian J Dermatol. 2015 Sep-Oct;60(5):520.
4 Organotin compounds enhance 17beta-hydroxysteroid dehydrogenase type I activity in human choriocarcinoma JAr cells: potential promotion of 17beta-estradiol biosynthesis in human placenta. Biochem Pharmacol. 2006 Apr 28;71(9):1349-57.
5 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
6 Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicol Lett. 2017 Nov 5;281:26-34. doi: 10.1016/j.toxlet.2017.09.001. Epub 2017 Sep 5.
7 Expression of the human ABCC6 gene is induced by retinoids through the retinoid X receptor. Biochem Biophys Res Commun. 2006 Dec 1;350(4):1082-7. doi: 10.1016/j.bbrc.2006.10.007. Epub 2006 Oct 10.
8 Investigation of the mechanisms by which EB1089 abrogates apoptosis induced by 9-cis retinoic acid in pancreatic cancer cells. Pancreas. 2006 Jan;32(1):93-100.
9 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
10 Effects of all-trans and 9-cis retinoic acid on differentiating human neural stem cells in vitro. Toxicology. 2023 Mar 15;487:153461. doi: 10.1016/j.tox.2023.153461. Epub 2023 Feb 16.
11 9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and precludes them to mature phenotype development. J Immunol. 2007 May 15;178(10):6130-9. doi: 10.4049/jimmunol.178.10.6130.
12 Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinoma. Tumour Biol. 2005 Nov-Dec;26(6):313-23. doi: 10.1159/000089262. Epub 2005 Oct 25.
13 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
14 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
15 Farnesoid X receptor: from structure to potential clinical applications. J Med Chem. 2005 Aug 25;48(17):5383-403.
16 The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo. Mol Endocrinol. 2001 Aug;15(8):1360-9.
17 Phytanic acid is a retinoid X receptor ligand. Eur J Biochem. 1996 Feb 15;236(1):328-33.
18 Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature. 2002 Jan 10;415(6868):187-92.
19 Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators thro... J Biol Chem. 2005 Jan 14;280(2):1625-33.
20 Activation of mammalian retinoid X receptors by the insect growth regulator methoprene. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):6157-60.
21 Vitamins and cofactors: highlights of ESBOC 2009. Nat Chem Biol. 2009 Aug;5(8):530-3.
22 DOI: 10.1038/scibx.2010.766
23 Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease.Oncotarget.2016 Feb 16;7(7):7469-79.
24 In vitro metabolic characterization, phenotyping, and kinetic studies of 9cUAB30, a retinoid X receptor-specific retinoid. Drug Metab Dispos. 2007 Jul;35(7):1157-64.
25 Silicon analogues of the RXR-selective retinoid agonist SR11237 (BMS649): chemistry and biology. ChemMedChem. 2009 Jul;4(7):1143-52.
26 Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature. 1996 Oct 3;383(6599):450-3.
27 Tamibarotene: a candidate retinoid drug for Alzheimer's disease. Biol Pharm Bull. 2012;35(8):1206-12.
28 Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.Expert Opin Ther Pat. 2016 Aug;26(8):957-71.
29 Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma. Biochem Biophys Res Commun. 1992 Jul 31;186(2):977-83.
30 Therapeutic applications for ligands of retinoid receptors. Curr Pharm Des. 2000 Jan;6(1):25-58.
31 Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist. J Med Chem. 2005 Dec 1;48(24):7517-9.
32 Rational design of RAR-selective ligands revealed by RARbeta crystal stucture. EMBO Rep. 2004 Sep;5(9):877-82.
33 9-cis-retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6117-22.
34 Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target. J Med Chem. 2004 Dec 30;47(27):6831-9.
35 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
36 Recent developments in receptor-selective retinoids. Curr Pharm Des. 2000 Jun;6(9):919-31.
37 Randomised controlled trial for emphysema with a selective agonist of the gamma-type retinoic acid receptor. Eur Respir J. 2012 Aug;40(2):306-12.
38 Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer. 2007 Mar 1;109(5):957-65.
39 Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica. 1998 Jun;28(6):539-47.
40 Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75.
41 Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos. 2013 Feb;41(2):263-9.
42 Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies. J Pharm Pharmacol. 2017 Dec;69(12):1762-1772.
43 Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates. Br J Pharmacol. 2012 Apr;165(8):2787-98.
44 Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos. 2007 Apr;28(3):151-6.
45 The metabolism of zidovudine by human liver microsomes in vitro: formation of 3'-amino-3'-deoxythymidine. Biochem Pharmacol. 1994 Jul 19;48(2):267-76.
46 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
47 Effects of 1 alpha,25-dihydroxy-vitamin D3 and calcipotriol on organotypic cultures of outer root sheath cells: a potential model to evaluate antipsoriatic drugs. Arch Dermatol Res. 1993;285(7):402-9. doi: 10.1007/BF00372133.
48 Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation. Mol Endocrinol. 1992 May;6(5):667-76. doi: 10.1210/mend.6.5.1318502.
49 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
50 Retinoic acid and hydroquinone induce inverse expression patterns on cornified envelope-associated proteins: implication in skin irritation. J Dermatol Sci. 2014 Nov;76(2):112-9. doi: 10.1016/j.jdermsci.2014.08.003. Epub 2014 Aug 26.
51 Correlation of chemopreventive efficacy data from the human epidermal cell assay with in vivo data. Anticancer Res. 2000 Jan-Feb;20(1A):27-32.
52 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
53 Deducing signaling pathways from parallel actions of arsenite and antimonite in human epidermal keratinocytes. Sci Rep. 2020 Feb 19;10(1):2890. doi: 10.1038/s41598-020-59577-0.
54 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
55 The psychoactive compound of Cannabis sativa, (9)-tetrahydrocannabinol (THC) inhibits the human trophoblast cell turnover. Toxicology. 2015 Aug 6;334:94-103. doi: 10.1016/j.tox.2015.06.005. Epub 2015 Jun 9.
56 Pharmacological doses of testosterone upregulated androgen receptor and 3-Beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase and impaired leydig cells steroidogenesis in adult rats. Toxicol Sci. 2011 Jun;121(2):397-407. doi: 10.1093/toxsci/kfr063. Epub 2011 Apr 6.
57 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
58 Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions. Mol Endocrinol. 2005 Oct;19(10):2502-16.
59 Peroxisome proliferator activated receptor gamma (PPAR-gama) ligand pioglitazone regulated gene networks in term human primary trophoblast cells. Reprod Toxicol. 2018 Oct;81:99-107.
60 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
61 Expression of cFABP and PPAR in trophoblast cells: effect of PPAR ligands on linoleic acid uptake and differentiation. Biochim Biophys Acta. 2005 Feb 21;1687(1-3):181-94. doi: 10.1016/j.bbalip.2004.11.017.
62 The inhibitory effects of manganese on steroidogenesis in rat primary Leydig cells by disrupting steroidogenic acute regulatory (StAR) protein expression. Toxicology. 2003 May 3;187(2-3):139-48. doi: 10.1016/s0300-483x(03)00063-5.
63 Endocrine disrupting effects of herbicides and pentachlorophenol: in vitro and in vivo evidence. Environ Sci Technol. 2009 Mar 15;43(6):2144-50. doi: 10.1021/es8028928.
64 Gene-specific TCDD suppression of RARalpha- and RXR-mediated induction of tissue transglutaminase. Toxicol Sci. 2002 Jul;68(1):102-8. doi: 10.1093/toxsci/68.1.102.
65 TCDD suppression of tissue transglutaminase stimulation by retinoids in malignant human keratinocytes. Toxicol Sci. 2000 Aug;56(2):357-64.
66 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
67 Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion. Toxicol In Vitro. 2009 Apr;23(3):486-99.
68 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
69 NF-kappaB-activated tissue transglutaminase is involved in ethanol-induced hepatic injury and the possible role of propolis in preventing fibrogenesis. Toxicology. 2008 Apr 18;246(2-3):148-57.
70 PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med. 2006 Oct 2;203(10):2351-62.
71 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
72 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
73 Citrullination of RGG Motifs in FET Proteins by PAD4 Regulates Protein Aggregation and ALS Susceptibility. Cell Rep. 2018 Feb 6;22(6):1473-1483. doi: 10.1016/j.celrep.2018.01.031.
74 Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 1;445:152603. doi: 10.1016/j.tox.2020.152603. Epub 2020 Sep 28.
75 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
76 Regulation of chromatin assembly and cell transformation by formaldehyde exposure in human cells. Environ Health Perspect. 2017 Sep 21;125(9):097019.
77 Sulforaphane-induced apoptosis in human leukemia HL-60 cells through extrinsic and intrinsic signal pathways and altering associated genes expression assayed by cDNA microarray. Environ Toxicol. 2017 Jan;32(1):311-328.
78 CD34+ derived macrophage and dendritic cells display differential responses to paraquat. Toxicol In Vitro. 2021 Sep;75:105198. doi: 10.1016/j.tiv.2021.105198. Epub 2021 Jun 9.
79 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
80 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
81 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
82 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
83 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
84 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
85 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
86 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
87 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
88 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
89 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
90 Evaluation of the sensitizing potential of antibiotics in vitro using the human cell lines THP-1 and MUTZ-LC and primary monocyte-derived dendritic cells. Toxicol Appl Pharmacol. 2012 Aug 1;262(3):283-92.
91 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
92 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
93 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
94 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
95 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
96 Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC Med Genomics. 2009 Aug 20;2:55. doi: 10.1186/1755-8794-2-55.
97 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
98 A pilot study on the transcriptional response of androgen- and insulin-related genes in peripheral blood mononuclear cells induced by testosterone administration in hypogonadal men. J Biol Regul Homeost Agents. 2011 Apr-Jun;25(2):291-4.
99 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
100 Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. Arch Toxicol. 2018 Jan;92(1):469-485.
101 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
102 The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Biol Chem. 2009 Sep 4;284(36):24306-19.
103 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
104 Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells. Mutat Res Genet Toxicol Environ Mutagen. 2014 Dec;775-776:48-54. doi: 10.1016/j.mrgentox.2014.10.011. Epub 2014 Nov 4.
105 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
106 Alteration of estrogen-regulated gene expression in human cells induced by the agricultural and horticultural herbicide glyphosate. Hum Exp Toxicol. 2007 Sep;26(9):747-52. doi: 10.1177/0960327107083453.
107 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
108 Extremely low copper concentrations affect gene expression profiles of human prostate epithelial cell lines. Chem Biol Interact. 2010 Oct 6;188(1):214-9.
109 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
110 Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell. 2004 Mar;15(3):1262-72. doi: 10.1091/mbc.e03-06-0360. Epub 2003 Dec 29.
111 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
112 A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci. 2005 Feb;83(2):282-92.
113 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
114 In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Toxicol Sci. 2007 Sep;99(1):162-73.
115 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
116 Activation of PPAR and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells. PLoS One. 2020 Aug 21;15(8):e0237976. doi: 10.1371/journal.pone.0237976. eCollection 2020.
117 Oral lichenoid eruption secondary to imatinib (Glivec). J Dermatolog Treat. 2004 Jul;15(4):253-5. doi: 10.1080/09546630410015556.
118 Impact of extracellular folate levels on global gene expression. Mol Pharmacol. 2001 Dec;60(6):1288-95. doi: 10.1124/mol.60.6.1288.
119 Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells. Cell Growth Differ. 1996 Aug;7(8):997-1004.
120 Methamphetamine alters the normal progression by inducing cell cycle arrest in astrocytes. PLoS One. 2014 Oct 7;9(10):e109603.
121 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
122 Detection of gene expression alteration of myeloma cells treated with arsenic trioxide. Zhonghua Xue Ye Xue Za Zhi. 2005 Apr;26(4):209-13.
123 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
124 Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound. Toxicol In Vitro. 2021 Jun;73:105112. doi: 10.1016/j.tiv.2021.105112. Epub 2021 Feb 22.
125 Transformation of human urothelial cells (UROtsa) by as and cd induces the expression of keratin 6a. Environ Health Perspect. 2008 Apr;116(4):434-40. doi: 10.1289/ehp.10279.
126 Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. BMC Genomics. 2006 Apr 3;7:68. doi: 10.1186/1471-2164-7-68.
127 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
128 Differential protein expression of peroxiredoxin I and II by benzo(a)pyrene and quercetin treatment in 22Rv1 and PrEC prostate cell lines. Toxicol Appl Pharmacol. 2007 Apr 15;220(2):197-210. doi: 10.1016/j.taap.2006.12.030. Epub 2007 Jan 9.
129 Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells. Toxicol Sci. 2011 Mar;120(1):109-22.
130 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
131 Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol Sci. 2001 Jan;59(1):185-92.
132 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
133 Effects of low-dose Bisphenol A on calcium ion influx and on genes of proliferation and differentiation in immortalized human gingival cells in vitro: The role of estrogen receptor beta. Dent Mater. 2017 Sep;33(9):1021-1032. doi: 10.1016/j.dental.2017.06.011. Epub 2017 Jul 9.
134 Prediction of drug-induced liver injury using keratinocytes. J Appl Toxicol. 2017 Jul;37(7):863-872. doi: 10.1002/jat.3435. Epub 2017 Jan 31.
135 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
136 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
137 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
138 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
139 ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
140 [Effects of As2O3 on tissue factor, plasminogen activator inhibitor-1 and -2 expression in NB4, HL-60 and THP-1 cells]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Oct;34(4):645-9.
141 Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray. Acta Pharmacol Sin. 2004 Oct;25(10):1327-33.
142 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
143 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
144 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
145 Aberrantly expressed genes in HaCaT keratinocytes chronically exposed to arsenic trioxide. Biomark Insights. 2011 Feb 8;6:7-16.
146 WNT7A/-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer. Oncogene. 2015 Jun;34(26):3452-62. doi: 10.1038/onc.2014.277. Epub 2014 Sep 1.
147 1 alpha,25-(OH)2 vitamin D3 enhances expression of the genes encoding Ca(2+)-binding proteins MRP-8 and MRP-14. Am J Physiol. 1992 Jan;262(1 Pt 1):C235-42. doi: 10.1152/ajpcell.1992.262.1.C235.
148 Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells. Environ Toxicol. 2017 Nov;32(11):2400-2413. doi: 10.1002/tox.22453. Epub 2017 Aug 10.
149 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
150 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
151 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
152 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
153 Unique signatures of stress-induced senescent human astrocytes. Exp Neurol. 2020 Dec;334:113466. doi: 10.1016/j.expneurol.2020.113466. Epub 2020 Sep 17.
154 Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol Lett. 2007 Mar 8;169(2):162-76. doi: 10.1016/j.toxlet.2007.01.006. Epub 2007 Jan 19.
155 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
156 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
157 Zinc induces chemokine and inflammatory cytokine release from human promonocytes. J Hazard Mater. 2011 Nov 30;196:335-41. doi: 10.1016/j.jhazmat.2011.09.035. Epub 2011 Sep 19.
158 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
159 Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring). 2010 Jan;18(1):27-34. doi: 10.1038/oby.2009.208. Epub 2009 Jun 25.
160 Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009 Aug 21;138(4):645-659. doi: 10.1016/j.cell.2009.06.034. Epub 2009 Aug 13.
161 Role of phenytoin in wound healing: microarray analysis of early transcriptional responses in human dermal fibroblasts. Biochem Biophys Res Commun. 2004 Feb 13;314(3):661-6. doi: 10.1016/j.bbrc.2003.12.146.
162 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
163 The genomic response of Ishikawa cells to bisphenol A exposure is dose- and time-dependent. Toxicology. 2010 Apr 11;270(2-3):137-49. doi: 10.1016/j.tox.2010.02.008. Epub 2010 Feb 17.
164 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
165 Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells. Toxicol Appl Pharmacol. 2009 Nov 1;240(3):355-66.
166 Keratinocyte differentiation marker suppression by arsenic: mediation by AP1 response elements and antagonism by tetradecanoylphorbol acetate. Toxicol Appl Pharmacol. 2001 Aug 1;174(3):302-11.
167 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
168 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
169 Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer. Chem Res Toxicol. 2015 Jun 15;28(6):1144-55. doi: 10.1021/tx500393y. Epub 2015 Jun 3.
170 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
171 Microarray-based detection and expression analysis of extracellular matrix proteins in drug?resistant ovarian cancer cell lines. Oncol Rep. 2014 Nov;32(5):1981-90. doi: 10.3892/or.2014.3468. Epub 2014 Sep 9.
172 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
173 Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer. Mol Oncol. 2011 Oct;5(5):438-53. doi: 10.1016/j.molonc.2011.07.003. Epub 2011 Jul 26.
174 Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer. 2007 Dec 11;7:223.
175 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
176 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
177 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
178 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
179 Integrated analysis of rifampicin-induced microRNA and gene expression changes in human hepatocytes. Drug Metab Pharmacokinet. 2014;29(4):333-40.
180 Genomic profiling uncovers a molecular pattern for toxicological characterization of mutagens and promutagens in vitro. Toxicol Sci. 2011 Jul;122(1):185-97.
181 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
182 Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res. 2006 Dec 1;66(23):11187-93. doi: 10.1158/0008-5472.CAN-06-1274.
183 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
184 Grouping of histone deacetylase inhibitors and other toxicants disturbing neural crest migration by transcriptional profiling. Neurotoxicology. 2015 Sep;50:56-70.
185 Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells. Br J Haematol. 2005 Sep;130(6):912-25. doi: 10.1111/j.1365-2141.2005.05696.x.
186 Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer. 2008 May 1;122(9):2115-24. doi: 10.1002/ijc.23315.
187 Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways. Food Chem Toxicol. 2021 Dec;158:112664. doi: 10.1016/j.fct.2021.112664. Epub 2021 Nov 9.
188 Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. Arthritis Rheum. 2008 Dec;58(12):3675-83.
189 PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J Lipid Res. 2007 Feb;48(2):373-84.
190 Organochloride pesticides modulated gut microbiota and influenced bile acid metabolism in mice. Environ Pollut. 2017 Jul;226:268-276.
191 Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes. Biochem Pharmacol. 2006 Feb 28;71(5):605-14.
192 Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells. Toxins (Basel). 2023 Feb 9;15(2):140. doi: 10.3390/toxins15020140.
193 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
194 Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells. J Steroid Biochem Mol Biol. 2003 May;85(1):1-8. doi: 10.1016/s0960-0760(03)00142-0.
195 Effects of metformin and pioglitazone combination on apoptosis and AMPK/mTOR signaling pathway in human anaplastic thyroid cancer cells. J Biochem Mol Toxicol. 2020 Oct;34(10):e22547. doi: 10.1002/jbt.22547. Epub 2020 Jun 26.
196 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
197 Differential modulation of pro- and anti-inflammatory cytokine receptors by N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxy-crotonic acid amide (A77 1726), the physiologically active metabolite of the novel immunomodulator leflunomide. Biochem Pharmacol. 1998 May 1;55(9):1523-9. doi: 10.1016/s0006-2952(97)00677-1.
198 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
199 Human 3D multicellular microtissues: an upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity. Toxicol Lett. 2019 Sep 15;312:34-44.
200 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
201 Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment. J Gynecol Oncol. 2010 Dec 30;21(4):255-61. doi: 10.3802/jgo.2010.21.4.255. Epub 2010 Dec 31.
202 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
203 Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol. 2005 Jul;73(3):189-98.
204 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
205 Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clin Cancer Res. 2008 Oct 15;14(20):6647-55.
206 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
207 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
208 Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells. Oncol Rep. 2008 Jun;19(6):1627-34.
209 Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-beta-dependent mechanisms. Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):E4558-66.
210 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
211 Myosin-mediated cytoskeleton contraction and Rho GTPases regulate laminin-5 matrix assembly. Cell Motil Cytoskeleton. 2004 Feb;57(2):107-17. doi: 10.1002/cm.10161.
212 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
213 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
214 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
215 Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther. 2007 Mar;6(3):1031-8. doi: 10.1158/1535-7163.MCT-06-0643. Epub 2007 Mar 5.
216 Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
217 Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol. 2018 Nov;33(11):1168-1181. doi: 10.1002/tox.22623. Epub 2018 Aug 27.
218 An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221089257. doi: 10.1177/09603271221089257.
219 Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification. Mol Cancer Ther. 2012 Jul;11(7):1557-64. doi: 10.1158/1535-7163.MCT-11-0934. Epub 2012 Jun 22.
220 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
221 Aspirin induces apoptosis in human leukemia cells independently of NF-kappaB and MAPKs through alteration of the Mcl-1/Noxa balance. Apoptosis. 2010 Feb;15(2):219-29. doi: 10.1007/s10495-009-0424-9.
222 Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis. 2005 Mar;20(2):139-46. doi: 10.1093/mutage/gei019. Epub 2005 Mar 22.
223 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
224 Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol. 2017 Nov 15;335:16-27. doi: 10.1016/j.taap.2017.09.017. Epub 2017 Sep 21.
225 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
226 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
227 Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.
228 Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. Cancer Biol Ther. 2004 May;3(5):470-6. doi: 10.4161/cbt.3.5.838. Epub 2004 May 9.
229 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
230 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
231 Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer. Endocr Relat Cancer. 2011 Apr 28;18(3):333-45. doi: 10.1530/ERC-10-0262. Print 2011 Jun.
232 Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620.
233 Methotrexate increases expression of cell cycle checkpoint genes via JNK activation. Arthritis Rheum. 2012 Jun;64(6):1780-9. doi: 10.1002/art.34342. Epub 2011 Dec 19.
234 Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells. Melanoma Res. 2008 Apr;18(2):85-94. doi: 10.1097/CMR.0b013e3282f60097.
235 The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer Res. 2005 Jan 1;65(1):18-25.
236 Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol. 2001 May 15;61(10):1205-15. doi: 10.1016/s0006-2952(01)00583-4.
237 Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem Pharmacol. 2008 May 15;75(10):1924-34. doi: 10.1016/j.bcp.2008.02.013. Epub 2008 Feb 17.
238 Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells. Anticancer Res. 2003 Jan-Feb;23(1A):267-73.
239 Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA. Cell Mol Immunol. 2007 Feb;4(1):59-63.
240 Steroid signalling in the ovarian surface epithelium. Trends Endocrinol Metab. 2005 Sep;16(7):327-33.
241 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
242 The H295R system for evaluation of endocrine-disrupting effects. Ecotoxicol Environ Saf. 2006 Nov;65(3):293-305.
243 Estrogenic endocrine disruptive components interfere with calcium handling and differentiation of human trophoblast cells. J Cell Biochem. 2003 Jul 1;89(4):755-70.
244 Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines. Invest New Drugs. 2007 Oct;25(5):491-7.
245 Acetaminophen Modulates the Expression of Steroidogenesis-Associated Genes and Estradiol Levels in Human Placental JEG-3 Cells. Toxicol Sci. 2021 Jan 6;179(1):44-52. doi: 10.1093/toxsci/kfaa160.
246 Decreased levels of H3K9ac and H3K27ac in the promotor region of ovarian P450 aromatase mediated low estradiol synthesis in female offspring rats induced by prenatal nicotine exposure as well as in human granulosa cells after nicotine treatment. Food Chem Toxicol. 2019 Jun;128:256-266. doi: 10.1016/j.fct.2019.03.055. Epub 2019 Apr 6.
247 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
248 The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects. Clin Cancer Res. 2016 May 15;22(10):2534-44. doi: 10.1158/1078-0432.CCR-15-1666. Epub 2016 Jan 5.
249 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
250 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
251 Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell. J Dent. 2021 Jun;109:103673. doi: 10.1016/j.jdent.2021.103673. Epub 2021 Apr 16.
252 Patterns of some extracellular matrix gene expression are similar in cells from cleft lip-palate patients and in human palatal fibroblasts exposed to diazepam in culture. Toxicology. 2009 Mar 4;257(1-2):10-6. doi: 10.1016/j.tox.2008.12.002. Epub 2008 Dec 9.
253 Protective effects of myricitrin against osteoporosis via reducing reactive oxygen species and bone-resorbing cytokines. Toxicol Appl Pharmacol. 2014 Nov 1;280(3):550-60.
254 Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007 Apr;12(3):328-40. doi: 10.1177/1087057107299261. Epub 2007 Mar 22.
255 Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G533-49. doi: 10.1152/ajpgi.00428.2013. Epub 2014 Jul 17.
256 The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg Am. 2001 Feb;83(2):201-11. doi: 10.2106/00004623-200102000-00007.
257 Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis Rheum. 2006 Apr;54(4):1298-308. doi: 10.1002/art.21723.
258 Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy. Invest Ophthalmol Vis Sci. 2012 Aug 31;53(9):5921-9. doi: 10.1167/iovs.12-9646.
259 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
260 The stability of cytokeratin 18 in human liver cells during colchicine-induced microtubule disruption. Food Chem Toxicol. 2001 Jan;39(1):85-9. doi: 10.1016/s0278-6915(00)00113-7.
261 Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol. 2014 Jul;45(1):448-58.
262 Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer. 2004 Mar 20;109(2):220-9. doi: 10.1002/ijc.11692.
263 Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo. Prostate. 2009 May 15;69(7):744-54. doi: 10.1002/pros.20923.
264 The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study. Nutr J. 2005 Mar 4;4:11.
265 Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci. 2003 Aug 15;73(13):1705-19. doi: 10.1016/s0024-3205(03)00515-0.
266 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
267 Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic Biol Med. 2012 Jul 1;53(1):44-50. doi: 10.1016/j.freeradbiomed.2012.04.031. Epub 2012 May 9.
268 Nitric oxide causes anoikis through attenuation of E-cadherin and activation of caspase-3 in human gastric carcinoma AZ-521 cells infected with Mycoplasma hyorhinis. J Vet Med Sci. 2010 Jul;72(7):869-74.
269 Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci. 1999 Aug;112 ( Pt 16):2657-66. doi: 10.1242/jcs.112.16.2657.
270 Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo. Chem Biol Interact. 2021 Nov 1;349:109641. doi: 10.1016/j.cbi.2021.109641. Epub 2021 Sep 14.
271 Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells. Biochem Biophys Res Commun. 2009 Mar 13;380(3):614-9. doi: 10.1016/j.bbrc.2009.01.134. Epub 2009 Jan 27.
272 Regulation of epithelial cell morphology and functions approaching to more in vivo-like by modifying polyethylene glycol on polysulfone membranes. PLoS One. 2012;7(4):e36110.
273 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
274 Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Biol Chem. 2006 Dec;387(12):1629-33. doi: 10.1515/BC.2006.203.
275 Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res. 2000 Feb;45(3):788-94. doi: 10.1016/s0008-6363(99)00369-7.
276 Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. Med Oncol. 2011 Dec;28(4):1395-404. doi: 10.1007/s12032-010-9603-3. Epub 2010 Jul 2.
277 Regulatory role of KEAP1 and NRF2 in PPAR expression and chemoresistance in human non-small-cell lung carcinoma cells. Free Radic Biol Med. 2012 Aug 15;53(4):758-68. doi: 10.1016/j.freeradbiomed.2012.05.041. Epub 2012 Jun 7.
278 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
279 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
280 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol. 2006 Oct;126(10):2178-89. doi: 10.1038/sj.jid.5700289. Epub 2006 Mar 30.
281 DNA microarray analysis of vitamin D-induced gene expression in a human colon carcinoma cell line. Physiol Genomics. 2004 Apr 13;17(2):122-9. doi: 10.1152/physiolgenomics.00002.2003.
282 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
283 Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells. Reprod Toxicol. 2020 Jan;91:74-91. doi: 10.1016/j.reprotox.2019.10.004. Epub 2019 Nov 8.
284 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
285 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
286 Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic. Oncotarget. 2015 Aug 28;6(25):21493-506. doi: 10.18632/oncotarget.4085.
287 Aldosterone augments LOX-1-mediated low-density lipoprotein uptake in human umbilical artery endothelial cells. Pharmacol Rep. 2010 Mar-Apr;62(2):311-8. doi: 10.1016/s1734-1140(10)70271-1.
288 Nifedipine prevents apoptosis of endothelial cells induced by oxidized low-density lipoproteins. J Cardiovasc Pharmacol. 2002 Jul;40(1):146-52. doi: 10.1097/00005344-200207000-00018.
289 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711. doi: 10.1371/journal.pone.0036711. Epub 2012 May 4.
290 Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol. 2000 Feb 1;164(3):1546-52. doi: 10.4049/jimmunol.164.3.1546.
291 Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic Biol Med. 2007 Jun 15;42(12):1826-37.
292 Histamine induces MUC5AC expression via a hCLCA1 pathway. Pharmacology. 2007;80(4):219-26. doi: 10.1159/000104419. Epub 2007 Jul 5.
293 Transient receptor potential vanilloid 1 receptors mediate acid-induced mucin secretion via Ca2+ influx in human airway epithelial cells. J Biochem Mol Toxicol. 2012 May;26(5):179-86. doi: 10.1002/jbt.20413. Epub 2012 May 7.
294 Assessing the respiratory toxicity of dihydroxyacetone using an in vitro human airway epithelial tissue model. Toxicol In Vitro. 2019 Sep;59:78-86. doi: 10.1016/j.tiv.2019.04.007. Epub 2019 Apr 5.
295 Agents associated with lung inflammation induce similar responses in NCI-H292 lung epithelial cells. Toxicol In Vitro. 2008 Oct;22(7):1782-8.
296 Inorganic arsenic exposure promotes malignant progression by HDAC6-mediated down-regulation of HTRA1. J Appl Toxicol. 2023 Aug;43(8):1214-1224. doi: 10.1002/jat.4457. Epub 2023 Mar 11.
297 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
298 Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells. Neoplasia. 2006 Sep;8(9):758-71.
299 Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chem Res Toxicol. 2015 May 18;28(5):927-34. doi: 10.1021/tx5005248. Epub 2015 Apr 3.
300 Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid. Haematologica. 2007 Jan;92(1):115-20.
301 Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. Chem Biol Interact. 2016 Aug 5;255:31-44.
302 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
303 Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014 May;9(5):774-82. doi: 10.4161/epi.28153. Epub 2014 Feb 13.
304 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
305 Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment. Toxicol Sci. 2010 Aug;116(2):467-76. doi: 10.1093/toxsci/kfq138. Epub 2010 May 10.
306 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
307 Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis. Leuk Res. 2006 May;30(5):607-23. doi: 10.1016/j.leukres.2005.09.007. Epub 2005 Oct 19.
308 Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. PLoS One. 2011;6(11):e27306. doi: 10.1371/journal.pone.0027306. Epub 2011 Nov 8.
309 Bupropion, an atypical antidepressant, induces endoplasmic reticulum stress and caspase-dependent cytotoxicity in SH-SY5Y cells. Toxicology. 2011 Jul 11;285(1-2):1-7. doi: 10.1016/j.tox.2011.02.006. Epub 2011 Feb 24.
310 Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells. Asian Pac J Cancer Prev. 2013;14(11):6469-73. doi: 10.7314/apjcp.2013.14.11.6469.
311 Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts. Haematologica. 2006 Mar;91(3):386-9.
312 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329-1339. doi: 10.1002/tox.22834. Epub 2019 Aug 21.
313 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
314 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
315 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
316 Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies. Toxicol Appl Pharmacol. 2021 Dec 15;433:115792. doi: 10.1016/j.taap.2021.115792. Epub 2021 Nov 3.
317 Association of Arsenic Exposure with Whole Blood DNA Methylation: An Epigenome-Wide Study of Bangladeshi Adults. Environ Health Perspect. 2019 May;127(5):57011. doi: 10.1289/EHP3849. Epub 2019 May 28.
318 Bisphenol A Represses Dopaminergic Neuron Differentiation from Human Embryonic Stem Cells through Downregulating the Expression of Insulin-like Growth Factor 1. Mol Neurobiol. 2017 Jul;54(5):3798-3812. doi: 10.1007/s12035-016-9898-y. Epub 2016 Jun 7.
319 Benzo[a]pyrene-induced changes in microRNA-mRNA networks. Chem Res Toxicol. 2012 Apr 16;25(4):838-49.
320 Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells. Neurosci Lett. 2006 Mar 13;395(3):185-90. doi: 10.1016/j.neulet.2005.10.096. Epub 2005 Dec 1.
321 Effects of four-week high-fructose diet on gene expression in skeletal muscle of healthy men. Diabetes Metab. 2008 Feb;34(1):82-5. doi: 10.1016/j.diabet.2007.08.004. Epub 2007 Dec 11.
322 Regulation of DR-5 protein and mitochondrial transmembrane potential by gemcitabine, a possible mechanism of gemcitabine-enhanced TRAIL-induced apoptosis. Oncol Rep. 2007 Sep;18(3):523-9.
323 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
324 Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol. 2011 Mar;13(3):267-79. doi: 10.1093/neuonc/noq195. Epub 2011 Feb 3.
325 Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions. BMC Genomics. 2008 Aug 7;9:376.
326 Death receptor 5 regulation during selenium-mediated apoptosis in human prostate cancer cells. Cancer Biol Ther. 2002 May-Jun;1(3):287-90. doi: 10.4161/cbt.83.
327 Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst. 2004 Dec 1;96(23):1769-80. doi: 10.1093/jnci/djh322.
328 Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid, bile acid and drug metabolism in human hepatocytes. Life Sci. 2016 Jul 1;156:47-56.
329 Evaluation of developmental toxicity using undifferentiated human embryonic stem cells. J Appl Toxicol. 2015 Feb;35(2):205-18.
330 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
331 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
332 Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival. Int J Gynecol Cancer. 2010 May;20(4):529-36. doi: 10.1111/IGC.0b013e3181d9273e.
333 Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res. 2007 Dec 15;67(24):12007-17. doi: 10.1158/0008-5472.CAN-07-2464.
334 Glyphosate-based herbicide induces long-lasting impairment in neuronal and glial differentiation. Environ Toxicol. 2022 Aug;37(8):2044-2057. doi: 10.1002/tox.23549. Epub 2022 Apr 29.
335 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615. doi: 10.1007/s00204-020-02970-5. Epub 2021 Jan 29.
336 Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107-114. doi: 10.1016/j.cbi.2017.06.005. Epub 2017 Jun 7.
337 The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study. Toxicol In Vitro. 2020 Aug;66:104884. doi: 10.1016/j.tiv.2020.104884. Epub 2020 May 8.
338 Melanogenesis and antioxidant defense system in normal human melanocytes cultured in the presence of chlorpromazine. Toxicol In Vitro. 2015 Feb;29(1):221-7.
339 PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells. J Cancer. 2015 Oct 29;6(12):1320-30. doi: 10.7150/jca.11126. eCollection 2015.
340 Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients. Matrix Biol. 2003 Nov;22(6):491-500. doi: 10.1016/j.matbio.2003.09.001.
341 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
342 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
343 Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes. Front Pharmacol. 2016 Apr 26;7:111.
344 Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem. 2002 May 10;277(19):16860-7.
345 Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril. J Cardiovasc Pharmacol. 2002 Oct;40(4):625-31.
346 Transcriptomic Analysis of Stem Cells Treated with Moringin or Cannabidiol: Analogies and Differences in Inflammation Pathways. Int J Mol Sci. 2019 Nov 30;20(23):6039. doi: 10.3390/ijms20236039.
347 Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer. Cancer Res. 2010 Feb 15;70(4):1314-22. doi: 10.1158/0008-5472.CAN-09-3292. Epub 2010 Feb 9.
348 PPAR-alpha ligands inhibit H2O2-mediated activation of transforming growth factor-beta1 in human mesangial cells. Antioxid Redox Signal. 2002 Dec;4(6):877-84. doi: 10.1089/152308602762197416.
349 Cannabidiol selectively modulates interleukin (IL)-1 and IL-6 production in toll-like receptor activated human peripheral blood monocytes. Toxicology. 2021 Dec;464:153016. doi: 10.1016/j.tox.2021.153016. Epub 2021 Nov 2.
350 Cytokine abnormalities in a patient with eosinophilic fasciitis. Ann Allergy Asthma Immunol. 2003 Apr;90(4):452-5. doi: 10.1016/S1081-1206(10)61832-7.
351 Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-beta1 secretion and enhances the anti-proliferative effect of 5-fluorouracil. Br J Pharmacol. 2009 Jun;157(3):362-70. doi: 10.1111/j.1476-5381.2009.00161.x. Epub 2009 Apr 9.
352 Enhanced apoptosis and transforming growth factor-beta1 expression in colorectal adenomas and carcinomas after Sulindac therapy. Dis Colon Rectum. 2001 Jul;44(7):1008-15. doi: 10.1007/BF02235490.
353 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Anticancer Res. 1999 May-Jun;19(3A):1689-97.
354 Cannabidiol induces osteoblast differentiation via angiopoietin1 and p38 MAPK. Environ Toxicol. 2020 Dec;35(12):1318-1325. doi: 10.1002/tox.22996. Epub 2020 Jul 13.
355 The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells. J Korean Med Sci. 2005 Jun;20(3):438-44. doi: 10.3346/jkms.2005.20.3.438.
356 Glucosamine promotes osteogenic differentiation of dental pulp stem cells through modulating the level of the transforming growth factor-beta type I receptor. J Cell Physiol. 2010 Oct;225(1):140-51.
357 Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment. Calcif Tissue Int. 2001 May;68(5):285-90.
358 A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells. Calcif Tissue Int. 2002 Jun;70(6):488-95.
359 Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J Cell Biochem. 2007 Aug 15;101(6):1430-8. doi: 10.1002/jcb.21259.
360 Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74.
361 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
362 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
363 Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells. Biol Pharm Bull. 2007 Feb;30(2):247-53. doi: 10.1248/bpb.30.247.
364 Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice. J Clin Invest. 1998 Oct 15;102(8):1609-16. doi: 10.1172/JCI3077.
365 Microarray analyses in dendritic cells reveal potential biomarkers for chemical-induced skin sensitization. Mol Immunol. 2007 May;44(12):3222-33.
366 Indomethacin inhibits cell growth of medullary thyroid carcinoma by reducing cell cycle progression into S phase. Exp Biol Med (Maywood). 2008 Nov;233(11):1433-40. doi: 10.3181/0804-RM-127. Epub 2008 Sep 12.
367 Effects and mechanisms of betulinic acid on improving EGFR TKI-resistance of lung cancer cells. Environ Toxicol. 2018 Nov;33(11):1153-1159.
368 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
369 Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells. Cancer Lett. 2007 Jan 8;245(1-2):103-11. doi: 10.1016/j.canlet.2005.12.034. Epub 2006 Feb 20.
370 Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance. Exp Cell Res. 2012 Jun 10;318(10):1146-59.
371 HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects. J Pharmacol Exp Ther. 2008 Jan;324(1):352-9. doi: 10.1124/jpet.107.128959. Epub 2007 Oct 10.
372 The induction of cytochrome P450 2E1 by ethanol leads to the loss of synaptic proteins via PPARalpha down-regulation. Toxicology. 2017 Jun 15;385:18-27.
373 The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. Int J Cancer. 2009 Jul 1;125(1):235-43. doi: 10.1002/ijc.24331.
374 Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):467-74. doi: 10.1097/00126334-200312150-00004.
375 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
376 ROS-dependent DNA damage contributes to crizotinib-induced hepatotoxicity via the apoptotic pathway. Toxicol Appl Pharmacol. 2019 Nov 15;383:114768. doi: 10.1016/j.taap.2019.114768. Epub 2019 Oct 19.
377 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
378 All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells. Cancer Lett. 2005 Jun 28;224(2):303-10. doi: 10.1016/j.canlet.2004.10.016. Epub 2004 Dec 8.
379 Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells. Chem Biol Interact. 2013 Apr 25;203(2):412-22. doi: 10.1016/j.cbi.2013.03.011. Epub 2013 Mar 22.
380 Cigarette smoke and asbestos activate poly-ADP-ribose polymerase in alveolar epithelial cells. J Investig Med. 2001 Jan;49(1):68-76. doi: 10.2310/6650.2001.34092.
381 The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol. 1999;13(6):338-47. doi: 10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7.
382 Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol In Vitro. 2021 Jun;73:105138. doi: 10.1016/j.tiv.2021.105138. Epub 2021 Mar 6.
383 Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther. 2005 Feb;4(2):291-304.
384 Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells. Clin Exp Immunol. 2007 May;148(2):288-95. doi: 10.1111/j.1365-2249.2007.03335.x. Epub 2007 Feb 7.
385 Establishment of a 13 genes-based molecular prediction score model to discriminate the neurotoxic potential of food relevant-chemicals. Toxicol Lett. 2022 Feb 1;355:1-18. doi: 10.1016/j.toxlet.2021.10.013. Epub 2021 Nov 5.
386 Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8.
387 Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One. 2011;6(11):e27265. doi: 10.1371/journal.pone.0027265. Epub 2011 Nov 11.
388 Arsenic metabolites affect expression of the neurofilament and tau genes: an in-vitro study into the mechanism of arsenic neurotoxicity. Toxicol In Vitro. 2007 Sep;21(6):1104-12. doi: 10.1016/j.tiv.2007.04.007. Epub 2007 Apr 27.
389 All-trans retinoic acid induced hypercalcemia in a patient with acute promyelocytic leukemia: its relation to increased PTH-rP. Int J Hematol. 1994 Feb;59(2):143-4.
390 Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer. Cancer. 2007 Sep 15;110(6):1313-20. doi: 10.1002/cncr.22922.
391 miRNA expression profiling in a human stem cell-based model as a tool for developmental neurotoxicity testing. Cell Biol Toxicol. 2013 Aug;29(4):239-57. doi: 10.1007/s10565-013-9250-5. Epub 2013 Aug 1.
392 A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica. Tohoku J Exp Med. 2008 May;215(1):55-9. doi: 10.1620/tjem.215.55.
393 Aspirin-induced blockade of NF-kappaB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells. Biochim Biophys Acta. 2006 Mar;1763(3):282-9. doi: 10.1016/j.bbamcr.2006.01.005. Epub 2006 Feb 21.
394 Effects of acute ethanol treatment on NCCIT cells and NCCIT cell-derived embryoid bodies (EBs). Toxicol In Vitro. 2010 Sep;24(6):1696-704. doi: 10.1016/j.tiv.2010.05.017. Epub 2010 May 26.
395 Toxicoproteomics reveals an effect of clozapine on autophagy in human liver spheroids. Toxicol Mech Methods. 2023 Jun;33(5):401-410. doi: 10.1080/15376516.2022.2156005. Epub 2022 Dec 19.
396 Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells. Ann Trop Med Parasitol. 2003 Apr;97(3):245-57. doi: 10.1179/000349803235001714.
397 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
398 Retinoic acid induces Gpx2 gene expression in MCF-7 human breast cancer cells. J Nutr. 1999 Oct;129(10):1846-54. doi: 10.1093/jn/129.10.1846.
399 Expression of gastrointestinal glutathione peroxidase is inversely correlated to the presence of hepatitis C virus subgenomic RNA in human liver cells. J Biol Chem. 2005 Mar 11;280(10):8831-41. doi: 10.1074/jbc.M413730200. Epub 2004 Dec 28.
400 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
401 Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2. Biochem Biophys Res Commun. 2019 Jun 11;513(4):834-840. doi: 10.1016/j.bbrc.2019.04.081. Epub 2019 Apr 16.
402 Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC. Chem Biol Interact. 2021 Nov 1;349:109652. doi: 10.1016/j.cbi.2021.109652. Epub 2021 Sep 11.
403 ?9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer. Oncol Lett. 2018 Jun;15(6):8527-8535. doi: 10.3892/ol.2018.8407. Epub 2018 Apr 2.
404 Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways. Toxicol In Vitro. 2017 Apr;40:324-335. doi: 10.1016/j.tiv.2017.01.019. Epub 2017 Feb 2.
405 1,25-Dihydroxyvitamin D3 suppresses gene expression of eukaryotic translation initiation factor 2 in human promyelocytic leukemia HL-60 cells. Cell Struct Funct. 2005;30(1):1-6. doi: 10.1247/csf.30.1.
406 Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. Carcinogenesis. 2011 May;32(5):686-94. doi: 10.1093/carcin/bgr025. Epub 2011 Feb 10.
407 Identification of potential biomarkers for predicting acute dermal irritation by proteomic analysis. J Appl Toxicol. 2011 Nov;31(8):762-72.
408 Analysis of gene expression induced by diethylstilbestrol (DES) in human primitive Mullerian duct cells using microarray. Cancer Lett. 2005 Apr 8;220(2):197-210.
409 Ornithine decarboxylase antizyme upregulates DNA-dependent protein kinase and enhances the nonhomologous end-joining repair of DNA double-strand breaks in human oral cancer cells. Biochemistry. 2007 Aug 7;46(31):8920-32. doi: 10.1021/bi7000328. Epub 2007 Jul 14.
410 Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction. Neuropharmacology. 2009 Jul;57(1):41-8. doi: 10.1016/j.neuropharm.2009.04.005. Epub 2009 Apr 22.
411 Nucleophosmin in the pathogenesis of arsenic-related bladder carcinogenesis revealed by quantitative proteomics. Toxicol Appl Pharmacol. 2010 Jan 15;242(2):126-35. doi: 10.1016/j.taap.2009.09.016. Epub 2009 Oct 7.
412 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
413 Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009 Apr;13(2):93-103. doi: 10.1089/omi.2008.0075.
414 Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells. Chem Res Toxicol. 2015 Oct 19;28(10):1903-13. doi: 10.1021/acs.chemrestox.5b00105. Epub 2015 Sep 21.
415 hiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation. Front Mol Neurosci. 2020 Jul 6;13:119. doi: 10.3389/fnmol.2020.00119. eCollection 2020.
416 Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum Mol Genet. 2012 Sep 15;21(18):4104-14. doi: 10.1093/hmg/dds239. Epub 2012 Jun 20.
417 Biological effects and metabolism of 9-cis-retinoic acid and its metabolite 9,13-di-cis-retinoic acid in HaCaT keratinocytes in vitro: comparison with all-trans-retinoic acid. Arch Dermatol Res. 2000 Dec;292(12):612-20. doi: 10.1007/s004030000189.
418 Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo. Br J Cancer. 2007 Jun 4;96(11):1675-83.
419 Molecular and metabolic retinoid pathways in human amniotic membranes. Biochem Biophys Res Commun. 2006 Aug 11;346(4):1207-16. doi: 10.1016/j.bbrc.2006.06.024. Epub 2006 Jun 12.
420 Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicol Sci. 2023 Feb 17;191(2):227-238. doi: 10.1093/toxsci/kfac131.
421 Involvement of the p38 MAPK signaling pathway in S-phase cell-cycle arrest induced by Furazolidone in human hepatoma G2 cells. J Appl Toxicol. 2013 Dec;33(12):1500-5. doi: 10.1002/jat.2829. Epub 2012 Oct 30.
422 Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism. Diabetologia. 2005 Mar;48(3):586-94. doi: 10.1007/s00125-005-1672-z. Epub 2005 Feb 24.
423 Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms. Cancer Res. 2005 Jul 15;65(14):6476-83. doi: 10.1158/0008-5472.CAN-05-0370.
424 Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutat Res. 2005 Aug 4;575(1-2):47-60. doi: 10.1016/j.mrfmmm.2005.03.002. Epub 2005 Apr 26.
425 DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis. 2004 Jul;25(7):1293-8.
426 Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line. Int Immunopharmacol. 2004 Dec 15;4(13):1587-601. doi: 10.1016/j.intimp.2004.07.010.
427 Suppression by (9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation. Toxicology. 2013 Aug 9;310:84-91. doi: 10.1016/j.tox.2013.05.009. Epub 2013 May 29.
428 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000 Mar 1;164(5):2405-11. doi: 10.4049/jimmunol.164.5.2405.
429 Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis. J Allergy Clin Immunol. 2004 Jul;114(1):137-43. doi: 10.1016/j.jaci.2004.03.021.
430 Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients. Exp Hematol. 2009 Jul;37(7):838-48. doi: 10.1016/j.exphem.2009.04.003. Epub 2009 May 14.
431 In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells. Mol Cancer Ther. 2005 Jun;4(6):885-900.
432 Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen. Clin Cancer Res. 2009 May 15;15(10):3406-15. doi: 10.1158/1078-0432.CCR-08-2099. Epub 2009 Apr 28.
433 Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signaling. Toxicol Sci. 2014 Jun;139(2):328-37. doi: 10.1093/toxsci/kfu053. Epub 2014 Mar 27.
434 Thyroid organotypic rat and human cultures used to investigate drug effects on thyroid function, hormone synthesis and release pathways. Toxicol Appl Pharmacol. 2012 Apr 1;260(1):81-8. doi: 10.1016/j.taap.2012.01.029. Epub 2012 Feb 8.
435 Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases. Toxicol Sci. 2019 Apr 1;168(2):430-442. doi: 10.1093/toxsci/kfy302.
436 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
437 Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid. 2005 Aug;15(8):835-40. doi: 10.1089/thy.2005.15.835.
438 Screening the ToxCast Phase 1 Chemical Library for Inhibition of Deiodinase Type 1 Activity. Toxicol Sci. 2018 Apr 1;162(2):570-581. doi: 10.1093/toxsci/kfx279.
439 Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem. 2003 May 16;278(20):18092-100. doi: 10.1074/jbc.M300265200. Epub 2003 Mar 13.
440 TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells. J Pathol. 2011 Feb;223(3):378-89. doi: 10.1002/path.2797. Epub 2010 Oct 29.
441 Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.
442 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
443 Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Cancer Res. 2005 Sep 1;65(17):7856-65. doi: 10.1158/0008-5472.CAN-05-1056.
444 Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther. 2008 Oct;7(10):1607-18.
445 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
446 Retinoic acid regulates the expression of photoreceptor transcription factor NRL. J Biol Chem. 2006 Sep 15;281(37):27327-34. doi: 10.1074/jbc.M605500200. Epub 2006 Jul 19.
447 Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol. 2006 Mar;79(3):529-38. doi: 10.1189/jlb.0205064. Epub 2005 Dec 30.
448 Vitamin D Counteracts an IL-23-Dependent IL-17A(+)IFN-(+) Response Driven by Urban Particulate Matter. Am J Respir Cell Mol Biol. 2017 Sep;57(3):355-366. doi: 10.1165/rcmb.2016-0409OC.
449 Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane. Bone. 2007 Apr;40(4):876-87. doi: 10.1016/j.bone.2006.11.029. Epub 2006 Dec 28.
450 Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. Biochem J. 2011 Sep 1;438(2):349-58. doi: 10.1042/BJ20101653.
451 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
452 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
453 The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia. 2005 Jan;48(1):83-95. doi: 10.1007/s00125-004-1619-9. Epub 2004 Dec 24.
454 The small polyphenolic molecule kaempferol increases cellular energy expenditure and thyroid hormone activation. Diabetes. 2007 Mar;56(3):767-76. doi: 10.2337/db06-1488.
455 Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes. Endocrinology. 2009 Apr;150(4):1976-83. doi: 10.1210/en.2008-0938. Epub 2008 Nov 26.
456 Characterization of a novel airway epithelial cell-specific short chain alcohol dehydrogenase/reductase gene whose expression is up-regulated by retinoids and is involved in the metabolism of retinol. J Biol Chem. 2001 Jun 29;276(26):24194-202. doi: 10.1074/jbc.M100332200. Epub 2001 Apr 13.
457 The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia. 2009 Jun;23(6):1019-28.
458 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
459 Gene regulation of CYP4F11 in human keratinocyte HaCaT cells. Drug Metab Dispos. 2010 Jan;38(1):100-7. doi: 10.1124/dmd.109.029025.
460 CYP4F2 repression and a modified alpha-tocopherol (vitamin E) metabolism are two independent consequences of ethanol toxicity in human hepatocytes. Toxicol In Vitro. 2017 Apr;40:124-133.
461 Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor co-activator-1 protein. Br J Pharmacol. 2010 Oct;161(4):771-81. doi: 10.1111/j.1476-5381.2010.00900.x.
462 Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells. Diabetologia. 2010 May;53(5):955-65. doi: 10.1007/s00125-010-1676-1. Epub 2010 Feb 18.
463 AMPK activator acadesine fails to alleviate isoniazid-caused mitochondrial instability in HepG2 cells. J Appl Toxicol. 2017 Oct;37(10):1219-1224. doi: 10.1002/jat.3483. Epub 2017 May 29.
464 Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis. Toxicol Appl Pharmacol. 2016 Jul 1;302:1-9. doi: 10.1016/j.taap.2016.04.007. Epub 2016 Apr 16.
465 A cardiac-specific robotized cellular assay identified families of human ligands as inducers of PGC-1 expression and mitochondrial biogenesis. PLoS One. 2012;7(10):e46753. doi: 10.1371/journal.pone.0046753. Epub 2012 Oct 3.
466 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
467 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
468 Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int J Cancer. 2004 Nov 1;112(2):200-12. doi: 10.1002/ijc.20401.